Improved Risk Stratification for Biochemical Recurrence after Radical Prostatectomy Using a Novel Risk Group System based on Prostate Specific Antigen Density and Biopsy Gleason Score
- 1 July 2002
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 168 (1) , 110-115
- https://doi.org/10.1016/s0022-5347(05)64841-0
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Is prostate specific antigen density an important prognostic indicator for patients with prostate cancer treated with external beam therapy?The British Journal of Radiology, 1998
- Re-examining the role of prostate-specific antigen density in predicting outcome for clinically localized prostate cancerUrology, 1997
- Prostate specific antigen density as a prognostic factor for patients with prostate carcinoma treated with radiotherapyCancer, 1996
- Prostate Specific Antigen Density is not an Independent Predictor of Response for Prostate Cancer Treated by Conformal RadiotherapyJournal of Urology, 1995
- Prostate specific antigen density in patients with histologically proven prostate carcinomaCancer, 1994
- Prostate specific antigen and prostate specific antigen density. Roles in patient evaluation and managementCancer, 1994
- Comparison of Prostate Specific Antigen with Prostate Specific Antigen Density for 3 Clinical ApplicationsJournal of Urology, 1994
- Predictive value of prostate-specific antigen density for the presence of micrometastatic carcinoma of the prostateUrology, 1994
- Prostate-specific antigen density: A new prognostic indicator for prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Prostate Specific Antigen Density: A Means of Distinguishing Benign Prostatic Hypertrophy and Prostate CancerJournal of Urology, 1992